Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ITRM will decline by -100.00% over the next 2 Weeks and hit $0.00 by Tuesday, April 14, 2026. In that time frame, ITRM's share price is expected to range between $0.00 and $0.03.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 14, 2026 | 0.00 | 0.04 | 0.08 |
| Apr 13, 2026 | 0.02 | 0.06 | 0.09 |
| Apr 10, 2026 | 0.01 | 0.05 | 0.09 |
| Apr 9, 2026 | 0.02 | 0.06 | 0.10 |
| Apr 8, 2026 | 0.04 | 0.08 | 0.12 |
| Apr 7, 2026 | 0.03 | 0.07 | 0.10 |
| Apr 6, 2026 | 0.05 | 0.08 | 0.12 |
| Apr 3, 2026 | 0.04 | 0.08 | 0.12 |
| Apr 2, 2026 | 0.05 | 0.09 | 0.13 |
| Apr 1, 2026 | 0.06 | 0.11 | 0.15 |
ITRM shares remained flat 0 in Tuesday, March 31, 2026's trading session, starting and closing at a previous close of $0.03 to move at $0.03. The stock demonstrated notable intraday movement (see ITRM's key stats for a full breakdown), fluctuating between $0.03 and $0.05, a +66.08% trading range. While recent weeks have seen some volatility, ITRM has managed to secure a -82.51% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 46.22M shares changing hands, 730.26M fewer than the previous session. This amounted to $1.39M in total market activity.
Will ITRM Continue Its Upward Trend?
According to analyst ratings and projections for ITRM, Iterum Therapeutics plc shares are anticipated to increase by +62.40%, potentially reaching $0.08 per share by April 14, 2026. Short-term technical indicators for ITRM currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the ITRM stock forecast, now is a good time to buy ITRM stock because its current trading price is -22.88% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ITRM covering social and institutional perspectives.
ITRM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ITRM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 22.97% to 28.17%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 34.33%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 39.58%, signals a bearish bias in the long-term trend. Insights into ITRM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Iterum Therapeutics Short-Term Forecasts
ITRM Forecast For Next 5 Days
Our algorithm anticipates Iterum Therapeutics (ITRM) stock could hit $0.07 by Apr 10, 2026. This represents a +142.33% rise from today's price, following a +0.43% change over the past five days.
ITRM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Iterum Therapeutics plc (ITRM) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.05, which would mean a +66.67% increase from the current price of $0.03. Projections for this period range from a high of $0.11 to a low of $0.00.
ITRM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Iterum Therapeutics's price over the next three months point to a rise. ITRM stock is expected to peak at $1.15 on Apr 03, 2026 before potentially dipping to $0.36 on Jul 03, 2026. On average, ITRM is likely to trade around $0.69 in the coming 90 days.
Iterum Therapeutics Stock Forecast 2025
Based on our predictive models, Iterum Therapeutics (ITRM) is expected to trade between $0.03 and $1.15 throughout 2026. This would result in an average price of $0.36, potentially offering investors a +1,100.00% return from current levels.
Iterum Therapeutics plc Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Iterum Therapeutics plc (ITRM) is positioned to show a strong performance in April 2026. The price is predicted to move between $0.79 and $1.15, settling at an average of $0.93. This could translate to a +3,000.00% gain.
May 2026
Based on current market signals, Iterum Therapeutics plc is projected to trend may 2026. We forecast a trading range from $0.56 to $0.86, with a likely average price of $0.69. Investors could expect a potential return of +2,200.00%.
June 2026
Our predictive algorithms indicate Iterum Therapeutics plc stock may see a shift in June 2026. The expected range spans $0.37–$0.63, with an average target of $0.50. This represents a positive outlook and a possible gain of +1,566.67%.
July 2026
Analyzing established trends, Iterum Therapeutics plc looks set to move in July 2026. Projections place the stock between $0.24 and $0.47, averaging around $0.36. This suggests a +1,100.00% gain from current levels.
August 2026
Market indicators suggest Iterum Therapeutics plc could experience notable changes during August 2026. Prices could fluctuate within $0.15 to $0.32, with a midpoint forecast of $0.25. The stock might deliver a +733.33% gain.
September 2026
Forecasting for September 2026, models estimate that Iterum Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.08 and $0.27, averaging $0.17. This signals a positive trajectory with potential returns around +466.67%.
October 2026
According to our latest forecast models, Iterum Therapeutics plc (ITRM) is positioned to show a strong performance in October 2026. The price is predicted to move between $0.06 and $0.20, settling at an average of $0.13. This could translate to a +333.33% gain.
November 2026
Based on current market signals, Iterum Therapeutics plc is projected to trend november 2026. We forecast a trading range from $0.05 to $0.22, with a likely average price of $0.15. Investors could expect a potential return of +400.00%.
December 2026
Our predictive algorithms indicate Iterum Therapeutics plc stock may see a shift in December 2026. The expected range spans $0.03–$0.21, with an average target of $0.13. This represents a positive outlook and a possible gain of +333.33%.
January 2027
Analyzing established trends, Iterum Therapeutics plc looks set to move in January 2027. Projections place the stock between $0.00 and $0.15, averaging around $0.09. This suggests a +200.00% gain from current levels.
February 2027
Market indicators suggest Iterum Therapeutics plc could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $0.11, with a midpoint forecast of $0.06. The stock might deliver a +100.00% gain.
March 2027
Forecasting for March 2027, models estimate that Iterum Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.09, averaging $0.04. This signals a positive trajectory with potential returns around +33.33%.
ITRM's history of dividends and stock splits also plays a role in long-term investor confidence.

